AstraZeneca chases biosimilar Avastin drug with Japanese group
 

AstraZeneca chases biosimilar Avastin drug with Japanese group
LONDON (Reuters) - AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin.


http://rc.feedsportal.com/r/23456606...28/rc/1/rc.img

http://rc.feedsportal.com/r/23456606...28/rc/2/rc.img

http://rc.feedsportal.com/r/23456606...28/rc/3/rc.img

http://da.feedsportal.com/r/23456606...5/sc/28/a2.img
http://adchoice.feedsportal.com/r/23.../sc/28/ach.imghttp://pi.feedsportal.com/r/23456606.../sc/28/a2t.imghttp://pi2.feedsportal.com/r/2345660...sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...5Y:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...5Y:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/91MJMSSznPs